TCL Archive In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads August 8, 1980
TCL Archive ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market September 26, 1997